Delivery Order SPE2DB24D1007-SPE2DB25FCCQW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units. This firm fixed-price delivery order, valued at $10,748.99, is scheduled for completion by September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis through competitive procurement procedures, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $14,885.28. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 14, 2025, with a ceiling value of $10,421.34 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for ultimate completion by July 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100 count) on June 3, 2025, with a ceiling value of $1,441.65 and an ultimate completion date of June 4, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order executed under AmerisourceBergen's existing pharmaceutical supply framework with the federal government. The pharmaceutical product will be performed at the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $3,562.06. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract value of $2,651.34. This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and represents work to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation applied. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Progesterone 200 mg capsules (100 count) with a ceiling value of $4,508.52. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside contract vehicle, with an ultimate completion date of August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Progesterone 200 mg capsules (100 count) under a firm fixed-price contract valued at $3,439.80. This non-set-aside delivery order will be completed by August 5, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,578.30 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100 count) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Progesterone 200 mg capsules (30-count units) with a contract value of $1,267.30. This firm fixed-price delivery order, which is scheduled for completion by July 17, 2025, carries no set-aside designation and represents a competitive award. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCQWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract valued at $3,845.77. This non-set-aside delivery order, with an ultimate completion date of July 30, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government, leveraging its capabilities as a major healthcare solutions provider and pharmaceutical distributor. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The company's federal contract portfolio demonstrates consistent competitive success in fulfilling medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 7/29/25 |